Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jand Medeiros |
| Publication date | November 9, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |